{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-26-000024","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2026-06-29T20:14:37+00:00","discovered_at":"2026-06-29T20:16:00.541158+00:00","generated_at":"2026-06-29T20:16:27.953055+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"confidence":"high","headline":"vTv Therapeutics annual meeting: three directors face over 1.8M withheld votes","bullets":["Stockholders elected 7 directors; Srinivas Akkaraju, Raymond Cheong, Daniel Spiegelman each received >1.8M withheld votes.","Fahed Al Marzooqi and Richard S. Nelson received strong support (2.4M for, 264K withheld).","Ratification of Ernst & Young as auditor passed with 99.9% for (2,964,869 for, 1,952 against).","Advisory say-on-pay vote: 686,535 for, 5,291 against, and 1,967,329 abstentions (310,535 broker non-votes)."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-26-000024","json":"https://secwatch.observer/filing/0001641489-26-000024.json","markdown":"https://secwatch.observer/filing/0001641489-26-000024.md","text":"https://secwatch.observer/filing/0001641489-26-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000024/0001641489-26-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000024/vtvt-20260626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T20:16:27.953055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}